See All Slides - tctmd.com

Slides

Presentation TCT 2016

SFA CTO Crossing Techniques: Choosing Between Intraluminal Crossing, Antegrade Subintimal Dissection With Re-entry, and Retrograde SFA Access

Presenter: Tony Das, Koen Deloose, Brian G. DeRubertis

October 31, 2016

Presentation TCT 2016

ABSORB III Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Ron Waksman

October 31, 2016

Presentation TCT 2016

MDIC and Industry Perspectives: Potential Effects of NEST on Research, Innovation and Patient Outcomes

Presenter: Owen Faris, Mitchell W. Krucoff, Michael R Minogue

October 31, 2016

Presentation TCT 2016

Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together?

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Robert W. Yeh

October 31, 2016

Presentation TCT 2016

Can Transcatheter Mitral Annuloplasty Provide a Long-term Solution for Secondary MR: Implications of the CTSN SMR Trial and Other Experiences

Presenter: Ted Feldman, Scott Lim, Steven F. Bolling

October 31, 2016

Presentation TCT 2016

What Have We Learned From Contemporary Left Main Observational Studies I? French and LEMAX Registries

Presenter: Seung-Jung Park, Leif Thuesen, Philippe Garot

October 31, 2016

Presentation TCT 2016

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing II: Biomechanical Perspectives

Presenter: Elazer R. Edelman, Juan F. Granada

October 31, 2016

Presentation TCT 2016

Malaysia Responds: How Would I Have Treated This Case in My Cath Lab?

Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari

October 31, 2016

Presentation TCT 2016

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

Presenter: Raj Makkar, Lars Sondergaard, Samir R. Kapadia

October 31, 2016

Presentation TCT 2016

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Presenter: Sunil V. Rao, Harvey D. White, Stephen G. Ellis

October 31, 2016

Advertisement

Slides

SFA CTO Crossing Techniques: Choosing Between Intraluminal Crossing, Antegrade Subintimal Dissection With Re-entry, and Retrograde SFA Access

ABSORB III Critique: Pros and Cons

MDIC and Industry Perspectives: Potential Effects of NEST on Research, Innovation and Patient Outcomes

Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together?

Can Transcatheter Mitral Annuloplasty Provide a Long-term Solution for Secondary MR: Implications of the CTSN SMR Trial and Other Experiences

What Have We Learned From Contemporary Left Main Observational Studies I? French and LEMAX Registries

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing II: Biomechanical Perspectives

Malaysia Responds: How Would I Have Treated This Case in My Cath Lab?

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content